High-Risk Drug Monitoring Service · Portsmouth

High-Risk Drug Monitoring Service in Portsmouth.

Systematic monitoring of high-risk medicines across the practice list — DMARDs, lithium, amiodarone, anticoagulants, valproate — with pharmacist-led recall and prescribing safety reporting. Delivered to Portsmouth PCNs and GP practices from the BCS Chiswick (West London) hub, with paired cover from our Halifax (West Yorkshire) hub — the only UK dual-hub clinical pharmacy model.

Portsmouth · local context

Portsmouth PCNs sit within NHS Hampshire and Isle of Wight ICB.

Portsmouth PCNs cover one of the south coast's most deprived urban patches — pharmacist programmes lean on CVD optimisation and high-risk drug monitoring.

For high-risk drug monitoring specifically, the Portsmouth pathway typically integrates with Portsmouth Hospitals University NHS Trust (Queen Alexandra). BCS standardises the cross-organisation workflow into a single hub-supervised process.

What you get

What high-risk drug monitoring in Portsmouth actually looks like.

  • Quarterly DMARD bloods recall and recording
  • Anticoagulant INR / DOAC reviews
  • Lithium and amiodarone monitoring cycles
  • Valproate Pregnancy Prevention Programme oversight
  • Safety alert action and audit evidence

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every high-risk drug monitoring placement in Portsmouth is mobilised from one of our two clinical hubs — Chiswick (West London) as the lead and Halifax (West Yorkshire) as paired cover. The dual-hub model is unique to BCS: same SOPs, same supervision, same-week cross-cover.

  • Lead delivery from the BCS Chiswick (West London) hub
  • Paired cover from BCS Halifax (West Yorkshire)
  • Same-week sickness, leave and maternity cover
  • ARRS-compliant, GPhC-registered workforce
  • One SLA, one report, one escalation point

Portsmouth · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in Portsmouth
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why Portsmouth PCNs choose BCS for high-risk drug monitoring.

Solo recruitment for high-risk drug monitoring in Portsmouth leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Chiswick (West London)/Halifax (West Yorkshire) dual-hub.

Frequently asked questions — High-Risk Drug Monitoring Service in Portsmouth.

Does BCS handle MHRA safety alert response?+

Yes — every active MHRA alert is mapped to a BCS pharmacist workflow with action evidence per practice.

Does BCS already deliver high-risk drug monitoring in Portsmouth?+

BCS supports PCNs across South East from our Chiswick (West London) hub with paired cover from Halifax (West Yorkshire), and is actively delivering or available to mobilise high-risk drug monitoring in Portsmouth. Get in touch and we'll confirm current capacity.

How quickly can BCS mobilise high-risk drug monitoring in Portsmouth?+

In most cases inside 4–6 weeks of contract sign-off, with HSCN-secured remote prescribing back-up available sooner where capacity is urgent.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call